OTLC
Price:
$0.03
Market Cap:
$12.19M
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. It also develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; and CA4P for the treatment of advanced metastatic melanoma. The company is headquartered in Agoura Hills, California.[Read more]
Industry
Biotechnology
IPO Date
1993-08-26
Stock Exchange
PNK
Ticker
OTLC
According to Oncotelic Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.01. This represents a change of -25.58% compared to the average of 0.02 of the last 4 quarters.
The mean historical Current Ratio of Oncotelic Therapeutics, Inc. over the last ten years is 4.47. The current 0.01 Current Ratio has changed -73.49% with respect to the historical average. Over the past ten years (40 quarters), OTLC's Current Ratio was at its highest in in the March 2015 quarter at 35.52. The Current Ratio was at its lowest in in the March 2022 quarter at 0.01.
Average
4.47
Median
0.37
Minimum
0.02
Maximum
21.39
Discovering the peaks and valleys of Oncotelic Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 276.95%
Maximum Annual Current Ratio = 21.39
Minimum Annual Increase = -94.15%
Minimum Annual Current Ratio = 0.02
Year | Current Ratio | Change |
---|---|---|
2023 | 0.02 | -8.09% |
2022 | 0.02 | -55.86% |
2021 | 0.04 | -26.27% |
2020 | 0.06 | 36.79% |
2019 | 0.04 | -94.15% |
2018 | 0.69 | -0.19% |
2017 | 0.69 | -92.09% |
2016 | 8.72 | -33.07% |
2015 | 13.02 | -39.10% |
2014 | 21.39 | 276.95% |
The current Current Ratio of Oncotelic Therapeutics, Inc. (OTLC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.02
5-year avg
0.03
10-year avg
4.47
Oncotelic Therapeutics, Inc.’s Current Ratio is less than Ceapro Inc. (7.10), less than PhaseBio Pharmaceuticals, Inc. (1.75), less than Processa Pharmaceuticals, Inc. (3.97), greater than Kaleido Biosciences, Inc. (0), greater than Advanced Proteome Therapeutics Corporation (0), less than Cellectis S.A. (1.92), less than ChitogenX Inc. (0.02), less than Biotron Limited (0.58), greater than Bioasis Technologies Inc. (0), less than Nascent Biotech, Inc. (0.31), less than ProtoKinetix, Incorporated (0.06), greater than RespireRx Pharmaceuticals Inc. (0.01), less than Silo Pharma, Inc. (5.84), greater than VG Life Sciences Inc. (0), less than Rubius Therapeutics, Inc. (0), less than Peak Bio, Inc. (2.54), less than AlloVir, Inc. (0), less than null (0.06), less than null (55.08),
Company | Current Ratio | Market cap |
---|---|---|
7.10 | $13.31M | |
1.75 | $0 | |
3.97 | $3.63M | |
0 | $4.26K | |
0 | $147.52K | |
1.92 | $183.12M | |
0.02 | $432.27K | |
0.58 | $13.08M | |
0 | $28.44M | |
0.31 | $9.48M | |
0.06 | $3.94M | |
0.01 | $730.84K | |
5.84 | $4.75M | |
0 | $2.11M | |
0 | $7.51M | |
2.54 | $1.62M | |
0 | $102.33M | |
0.06 | $0 | |
55.08 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncotelic Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oncotelic Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Oncotelic Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Oncotelic Therapeutics, Inc. (OTLC)?
What is the highest Current Ratio for Oncotelic Therapeutics, Inc. (OTLC)?
What is the 3-year average Current Ratio for Oncotelic Therapeutics, Inc. (OTLC)?
What is the 5-year average Current Ratio for Oncotelic Therapeutics, Inc. (OTLC)?
How does the current Current Ratio for Oncotelic Therapeutics, Inc. (OTLC) compare to its historical average?